Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Human hair protein modifications could potentially indicate heart disease risk.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Women with irregular periods have a higher risk of heart disease.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Skin symptoms are important for diagnosing infections in children.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Electrospun nanofibers might be a promising new treatment for hair loss.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.